Related Experiment Video
Updated: Mar 27, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Adjunctive Habit Reversal Therapy in Treatment of Lichen Simplex Chronicus (Neurodermatitis): A Comparative, Pilot
Naveen Kumar Kansal1, Ramesh Pratap Anuragi1, Riti Bhatia1
1From the Department of Dermatology and Venereology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Background And Objectives:
Lichen simplex chronicus (LSC) is a common dermatosis with a habitual itch-scratch cycle and associated psychological elements. Therefore, psychological methods, such as habit reversal, to break the scratching behaviour may have a therapeutic benefit in this condition. Our objective in this study was to assess additional clinical effects of habit reversal therapy when combined with standard therapeutic measures (i.e. topical corticosteroids, antihistamines, and emollients).
Patients And Methods:
Thirty-four patients with LSC were divided into two groups: group A (standard therapy with adjunctive habit reversal therapy, the intervention group) and group B (standard therapy alone). The patients were taught the habit reversal therapy and followed up for 4 months. Clinical assessment and Dermatology Life Quality Index (DLQI) questionnaire were performed at every visit.
Results:
In various parameters of LSC, including induration, skin markings, itching, and scratching, a significantly better response was seen in group A. Group A also had a better DLQI score. Patients' perception of the psychological intervention was good.
Conclusions:
The addition of habit reversal therapy with standard treatments of LSC significantly improved the treatment outcome. Therefore, combining psychological interventions with approved therapies may benefit chronic dermatological conditions in appropriate clinical settings.
More Related Videos
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Hand hygiene
Hand washing...
Acne Infection
Direct-Acting Cholinergic Agonists: Therapeutic Uses

